Tolvaptan
A benzazepine derivative and selective VASOPRESSIN V2 RECEPTOR antagonist that is used to treat euvolemic and hypervolemic HYPONATREMIA. It is also used in the treatment of rapidly progressing AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE to slow the rate of cyst development and renal insufficiency.
Year introduced: 2019 (1999)
PubMed search builder options
Subheadings:
Tree Number(s): D03.633.100.079.875
MeSH Unique ID: D000077602
Registry Number: 21G72T1950
Entry Terms:
- 7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine
- OPC 41061
- OPC-41061
- OPC41061
- Samsca
Pharmacologic Action: